Skip to Content

Victory Value Institutional UIVAX

Medalist Rating as of | See Victory Capital Investment Hub
  • NAV / 1-Day Return 20.65  /  −0.72 %
  • Total Assets 1.3 Bil
  • Adj. Expense Ratio
    0.860%
  • Expense Ratio 0.860%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Large Value
  • Investment Style Mid Value
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 1.18%
  • Turnover 43%

USD | NAV as of Jul 18, 2024 | 1-Day Return as of Jul 18, 2024, 10:25 PM GMT+0

Morningstar’s Analysis UIVAX

Will UIVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Victory Value Institutional's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings UIVAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 17.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

2.55 32.4 Mil
Financial Services

The Goldman Sachs Group Inc

2.19 27.7 Mil
Financial Services

Merck & Co Inc

1.99 25.2 Mil
Healthcare

Alphabet Inc Class A

1.91 24.3 Mil
Communication Services

Citigroup Inc

1.57 19.9 Mil
Financial Services

The Cigna Group

1.52 19.3 Mil
Healthcare

Fairfax Financial Holdings Ltd

1.43 18.1 Mil
Financial Services

Keurig Dr Pepper Inc

1.41 18.0 Mil
Consumer Defensive

Applied Materials Inc

1.38 17.5 Mil
Technology

AbbVie Inc

1.36 17.2 Mil
Healthcare